欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0792/001
药品名称SmofKabiven
活性成分
    • Sodium acetate 1.7 g
    • Sodium glycerophosphate 2.1 g
    • Serine 3.3 g
    • Isoleucine 2.5 g
    • Histidine 1.5 g
    • Glycine 5.6 g
    • Glucose monohydrate 127.0 g
    • Glucose 42.0 %
    • fish oil, rich in omega 3-acids 4.2 g
    • Threonine 2.2 g
    • Taurine 0.5 g
    • SOYBEAN OIL monohydrate 114.0 g
    • Proline 5.7 g
    • Potassium chloride 2.3 g
    • Phenylalanine 2.6 g
    • OLIVE OIL monohydrate 9.5 g
    • Methionine 2.2 g
    • medium-chain triglycerides 8.5 g
    • Magnesium sulfate 0.38 g
    • Lysine 3.4 g
    • Leucine 3.8 g
    • Calcium chloride 0.28 g
    • Arginine 6.1 g
    • Alanine 7.1 g
    • Tryptophan 1.0 g
    • Zinc sulfate 0.0 g
    • Valine 3.1 g
    • Tyrosine 0.2 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      SmofKabiven zentral Emulsion zur Infusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Smofkabiven
    • Latvia (LV)
    • Lithuania (LT)
      SmofKabiven Central infuzinė emulsija
    • Estonia (EE)
    • Hungary (HU)
      SMOFKABIVEN emulziós infúzió
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
      SMOFKABIVEN CENTRAL, emulsie perfuzabila
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2008/04/16
最近更新日期2025/02/07
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase